These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8409060)

  • 21. Safety of the transpulmonary ultrasound contrast agent NC100100: a clinical and haemodynamic evaluation in patients with suspected or proved coronary artery disease.
    Myreng Y; Molstad P; Ytre-Arne K; Aas M; Stoksflod L; Nossen JO; Oftedal B
    Heart; 1999 Sep; 82(3):333-5. PubMed ID: 10455084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differing susceptibility of echocardiographic contrast agents to adverse effects of biologic factors: multicenter, videodensitometric comparison of octafluoropropane-filled microspheres with air-filled microspheres for left ventricular opacification.
    Hausnerova E; Gottdiener JS; Gould JJ; Pezzullo JC; Callahan JD; Cohen JL; Bruns DE; Kuvelas MT; West HE; Dittrich HC
    J Am Soc Echocardiogr; 1999 Nov; 12(11):957-66. PubMed ID: 10552357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Concomitant hemodynamic effects of intracoronary injections of a new transpulmonary contrast medium].
    Schröder T; Hering JP; Hellige G
    Ultraschall Med; 1995 Apr; 16(2):70-2. PubMed ID: 7624759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular opacification after intravenous injection of Albunex. The effect of different administration procedures.
    Sonne HS; Christensen PD; Muan B; Assentoft J; Haider T; Kristensen BO
    Int J Card Imaging; 1995 Mar; 11(1):47-53. PubMed ID: 7730681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sonicated albumin in exercise echocardiography: technique and feasibility to enhance endocardial visualization.
    Yvorchuk KJ; Sochowski RA; Chan KL
    J Am Soc Echocardiogr; 1996; 9(4):462-9. PubMed ID: 8827629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing the dose and rate of Albunex infusion leads to superior left ventricular contrast effect.
    Dolan MS; Dent J; deFilippi C; Christopher T; Wible JH; Labovitz AJ
    J Am Soc Echocardiogr; 1998 May; 11(5):426-32. PubMed ID: 9619613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-dimensional contrast echocardiography. II. Transpulmonary studies.
    Ten Cate FJ; Feinstein S; Zwehl W; Meerbaum S; Fishbein M; Shah PM; Corday E
    J Am Coll Cardiol; 1984 Jan; 3(1):21-7. PubMed ID: 6690551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digital radiofrequency echocardiography in the detection of myocardial contrast following intravenous administration of Albunex.
    Monaghan MJ; Metcalfe JM; Odunlami S; Waaler A; Jewitt DE
    Eur Heart J; 1993 Sep; 14(9):1200-9. PubMed ID: 8223734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a relation between inspired gas mixture and the left ventricular contrast achieved with Albunex in a canine model.
    Geiser EA; Buss DD; Wible JH; Cunningham MS; Webb AI; Wilson DC; Yang M
    Clin Cardiol; 1996 Apr; 19(4):289-95. PubMed ID: 8706368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transpulmonary passage of Albunex as a marker of intracardiac hemodynamics and outcome in chronic congestive heart failure.
    Sherman HL; Avelar E; Grossman PM; Sachdev V; Oral H; Nicklas JM; Armstrong WF
    Am Heart J; 2000 May; 139(5):782-7. PubMed ID: 10783210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Contrast agent improves diagnostic value of dobutamine stress echocardiography].
    Uehara H; Yamamoto T; Hirano Y; Ozasa Y; Yamada S; Ikawa H; Ishikawa K
    J Cardiol; 2001 Mar; 37(3):135-41. PubMed ID: 11281053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Albunex infusion on left ventricular inflow velocity in dogs.
    Tomita M; Wada H; Tanaka R; Miwa Y; Kagawa K; Noda T; Nishigaki K; Hirakawa S; Fujiwara H
    J Cardiol; 1997 May; 29(5):283-91. PubMed ID: 9174884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous injection of Albunex microspheres causes thromboxane mediated pulmonary hypertension in pigs, but not in monkeys or rabbits.
    Ostensen J; Hede R; Myreng Y; Ege T; Holtz E
    Acta Physiol Scand; 1992 Mar; 144(3):307-15. PubMed ID: 1533987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does cardiac function modify left heart opacification with transpulmonary echo contrast agents?
    Völler H; Schröder K; Spielberg C; Uhrig A; Wilkenshoff U; Dissmann R; Schlief R; Schröder R
    Echocardiography; 1993 Jan; 10(1):41-7. PubMed ID: 10148115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous contrast echocardiography with use of sonicated albumin in humans: systolic disappearance of left ventricular contrast after transpulmonary transmission.
    Shapiro JR; Reisner SA; Lichtenberg GS; Meltzer RS
    J Am Coll Cardiol; 1990 Dec; 16(7):1603-7. PubMed ID: 2254545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular volume determination using Albunex.
    Zotz RJ; Genth S; Waaler A; Erbel R; Meyer J
    J Am Soc Echocardiogr; 1996; 9(1):1-8. PubMed ID: 8679229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular opacification after peripheral venous injection of a modified albumin solution.
    Lin SL; Lo JH; Mou CY; Ho SJ; Liu RH; Chan JY; Chang MS; Chiang HT; Chen CY
    Int J Card Imaging; 1992; 8(1):53-61. PubMed ID: 1619305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing albunex in the left ventricle: an analysis of the technical parameters of four ultrasound systems in canines and humans.
    Block RJ; Brodsky L; Ostoic T; Fernandez A; Hickle P; Devries S; Bieniarz T; In M; Feinstein SB
    J Am Soc Echocardiogr; 1996; 9(6):787-94. PubMed ID: 8943438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and adverse effects of transpulmonary contrast echocardiography using sonicated albumin.
    Nakatani S; Beppu S; Ohta T; Matsuda H; Miyatake K
    Intern Med; 1994 Apr; 33(4):204-9. PubMed ID: 8069014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.